Hypoxia and fetal heart development

Current Molecular Medicine

Volumn 10, Issue 7, 2010, Pages 653-666

  Patterson, A J ^a   Zhang, L ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Fetal heart; Fetal programming; Hypoxia

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 70; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN KINASE C EPSILON; VASCULOTROPIN;

ARTICLE; EPIGENETICS; FETUS; FETUS HEART; GENE EXPRESSION; GENETIC PREDISPOSITION; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMIC STRESS; HUMAN; HYPOXIA; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN TENSION; PERINATAL DEVELOPMENT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

CORONARY VESSELS; EPIGENOMICS; FETAL DEVELOPMENT; FETAL HEART; FETAL HYPOXIA; FETUS; GENE EXPRESSION; HEART; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; ORGANOGENESIS; OXYGEN; PROTEIN KINASE C-EPSILON; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957973733     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652410792630643     Document Type: Article

References (166)

1. Webster WS, Abela D. The effect of hypoxia in development. Birth Defects Res C Embryo Today 2007; 81: 215-28.
2. Gross MW, Karbach U, Groebe K, Franko AJ, Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 1995; 61: 567-73.
3. Raleigh JA, Calkin-Adams DP, Rinker LH, et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 1998; 58: 3765-8.
4. Flueck M. Plasticity of the muscle proteome to exercise at altitude. High Alt Med Biol 2009; 10: 183-93.
5. Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol 2009; 219: 271-5.
6. Fisher SA, Burggren WW. Role of hypoxia in the evolution and development of the cardiovascular system. Antioxid Redox Signal 2007; 9: 1339-52.
7. Lawrence J, Xiao D, Xue Q, Rejali M, Yang S, Zhang L. Prenatal nicotine exposure increases heart susceptibility to ischemia/reperfusion injury in adult offspring. J Pharmacol Exp Ther 2008; 324: 331-41.
8. Reynolds JD, Penning DH, Dexter F, et al. Ethanol increases uterine blood flow and fetal arterial blood oxygen tension in the near-term pregnant ewe. Alcohol 1996; 13: 251-6.
9. Mitchell JA, Van Kainen BR. Effects of alcohol on intrauterine oxygen tension in the rat. Alcohol Clin Exp Res 1992; 16: 308-10.
10. Jensen A, Garnier Y, Berger R. Dynamics of fetal circulatory responses to hypoxia and asphyxia. Eur J Obstet Gynecol Reprod Biol 1999; 84: 155-72.
11. Myatt L. Placental adaptive responses and fetal programming. J Physiol 2006; 572: 25-30.
12. Ascuitto RJ, Ross-Ascuitto NT. Substrate metabolism in the developing heart. Semin Perinatol 1996; 20: 542-63.
13. Compernolle V, Brusselmans K, Franco D, et al. Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res 2003; 60: 569-79.
14. Sugishita Y, Leifer DW, Agani F, Watanabe M, Fisher SA. Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Dev Biol 2004; 273: 285-96.
15. Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH. Developmental patterning of the myocardium. Anat Rec 2000; 258: 319-37.
16. Fishman MC, Chien KR. Fashioning the vertebrate heart: earliest embryonic decisions. Development 1997; 124: 2099-117.
17. Wikenheiser J, Doughman YQ, Fisher SA, Watanabe M. Differential levels of tissue hypoxia in the developing chicken heart. Dev Dyn 2006; 235: 115-23.
18. Nanka O, Valasek P, Dvorakova M, Grim M. Experimental hypoxia and embryonic angiogenesis. Dev Dyn 2006; 235: 723-33.
19. Hoerter JA, Vassort G. Participation of the sarcolemma in the control of relaxation of the mammalian heart during perinatal development. Adv Myocardiol 1982; 3: 373-80.
20. Jonker SS, Zhang L, Louey S, Giraud GD, Thornburg KL, Faber JJ. Myocyte enlargement, differentiation, and proliferation kinetics in the fetal sheep heart. J Appl Physiol 2007; 102: 1130-42.
21. Rudolph AM. Myocardial growth before and after birth: clinical implications. Acta Paediatr 2000; 89: 129-33.
22. Oberpriller JO, Oberpriller JC. Response of the adult newt ventricle to injury. J Exp Zool 1974; 187: 249-53.
23. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002; 298: 2188-90.
24. Bettencourt-Dias M, Mittnacht S, Brockes JP. Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J Cell Sci 2003; 116: 4001-9
25. Engel FB, Schebesta M, Duong MT, et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005; 19: 1175-87.
26. Barbera A, Giraud GD, Reller MD, et al. Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1157-64.
27. Jonker SS, Zhang L, Louey S, Giraud GD, Thornburg KL, Faber JJ. Sequential growth of fetal sheep cardiac myocytes in response to simultaneous arterial and venous hypertension. Am J Physiol Regul Integr Comp Physiol 2007; 292: R913-9.
28. Kamitomo M, Longo LD, Gilbert RD: Cardiac function in fetal sheep during two weeks of hypoxemia. Am J Physiol 1994; 266: R1778-85.
29. Breuer E, Barta E, Zlatos L, Pappova E. Developmental changes of myocardial metabolism. II. Myocardial metabolism of fatty acids in the early postnatal period in dogs. Biol Neonat 1968; 12: 54-64.
30. Chapman JD. Hypoxic sensitizers-implications for radiation therapy. N Engl J Med 1979; 301: 1429-32.
31. Evans SM, Du KL, Chalian AA, et al. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys 2007; 69: 1024-31.
32. Evans SM, Jenkins KW, Jenkins WT, et al. Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res 2008; 170: 677-90.
33. Koch CJ, Evans SM. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles. Adv Exp Med Biol 2003; 510: 285-92.
34. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998; 12: 149-62.
35. Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 1998; 8: 588-94.
36. Ward J. Oxygen sensors in context. Biochim Biophys Acta 2008; 1777: 1-14.
37. Jiang BH, Rue E, Wang GL, Roe R, Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 1996; 271: 17771-8.
38. Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 2008; 141: 14-31.
39. Marzo F, Lavorgna A, Coluzzi G, et al. Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis 2008; 26: 183-7.
40. Watanabe M, Jafri A, Fisher SA. Apoptosis is required for the proper formation of the ventriculo-arterial connections. Dev Biol 2001; 240: 274-88.
41. Barbosky L, Lawrence DK, Karunamuni G, et al. Apoptosis in the developing mouse heart. Dev Dyn 2006; 235: 2592-602.
42. Druyan S, Cahaner A, Ashwell CM. The expression patterns of hypoxia-inducing factor subunit alpha-1, heme oxygenase, hypoxia upregulated protein 1, and cardiac troponin T during development of the chicken heart. Poult Sci 2007; 86: 2384-9.
43. Duranteau J, Chandel NS, Kulisz A, et al. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 1998; 273: 11619-24.
44. Lee YM, Jeong CH, Koo SY, et al. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 2001; 220: 175-86.
45. Sugishita Y, Watanabe M, Fisher SA. Role of myocardial hypoxia in the remodeling of the embryonic avian cardiac outflow tract. Dev Biol 2004; 267: 294-308.
46. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992; 80: 283-5.
47. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks' gestation. Am J Obstet Gynecol 2001; 184: 998-1003.
48. Soothill PW, Nicolaides KH, Rodeck CH, Campbell S. Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther 1986; 1: 168-75.
49. Pringle KG, Kind KL, Sferruzzi-Perri AN, Thompson JG, Roberts CT. Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Hum Reprod 2010; 16: 415-31
50. Covassin LD, Villefranc JA, Kacergis MC, Weinstein BM, Lawson ND. Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish. Proc Natl Acad Sci USA 2006; 103: 6554-9.
51. Nasevicius A, Larson J, Ekker SC. Distinct requirements for zebrafish angiogenesis revealed by a VEGF-A morphant. Yeast 2000; 17: 294-301.
52. Martyn U, Schulte-Merker S. Zebrafish neuropilins are differentially expressed and interact with vascular endothelial growth factor during embryonic vascular development. Dev Dyn 2004; 231: 33-42.
53. Weinstein BM, Lawson ND. Arteries, veins, Notch, and VEGF. Cold Spring Harb Symp Quant Biol 2002; 67: 155-62.
54. Papetti M, Herman IM. Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol 2002; 282: C947-70.
55. Josko J, Gwozdz B, Jedrzejowska-Szypulka H, Hendryk S. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis. Med Sci Monit 2000; 6: 1047-52.
56. Roskoski R, Jr. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun 2008; 375: 287-91.
57. Yla-Herttuala S, Rissanen TT, Vajanto I, Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J Am Coll Cardiol 2007; 49: 1015-26.
58. Tomanek RJ, Lotun K, Clark EB, Suvarna PR, Hu N. VEGF and bFGF stimulate myocardial vascularization in embryonic chick. Am J Physiol 1998; 274: H1620-26
59. Tomanek RJ, Ratajska A, Kitten GT, Yue X, Sandra A. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn 1999; 215: 54-61.
60. Tomanek RJ, Lund DD, Yue X. Hypoxic induction of myocardial vascularization during development. Adv Exp Med Biol 2003; 543: 139-49.
61. Giordano FJ, Gerber HP, Williams SP, et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci USA 2001; 98: 5780-5.
62. Takeuchi S, Takeda K, Oishi I, et al. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 2000; 5: 71-8.
63. Yue X, Tomanek RJ. Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in cultured embryonic hearts. Dev Dyn 1999; 216: 28-36.
64. Lainakis G, Bamias A. Targeting angiogenesis in renal cell carcinoma. Curr Cancer Drug Targets 2008; 8: 349-58.
65. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 2003; 23: 9361-74.
66. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-13.
67. Kotch LE, Iyer NV, Laughner E, Semenza GL. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999; 209: 254-67.
68. Edelberg JM, Aird WC, Wu W, et al. PDGF mediates cardiac microvascular communication. J Clin Invest 1998; 102: 837-43.
69. Liu H, Fisher SA. Hypoxia-inducible transcription factor-1alpha triggers an autocrine survival pathway during embryonic cardiac outflow tract remodeling. Circ Res 2008; 102: 1331-9.
70. Semenza GL, Agani F, Iyer N, et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci 1999; 874: 262-8.
71. Galanis A, Pappa A, Giannakakis A, Lanitis E, Dangaj D, Sandaltzopoulos R. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett 2008; 266: 12-20.
72. Adelman DM, Gertsenstein M, Nagy A, Simon MC, Maltepe E. Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev 2000; 14: 3191-203.
73. Cowden Dahl KD, Fryer BH, Mack FA, et al. Hypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation. Mol Cell Biol 2005; 25: 10479-91.
74. Covello KL, Kehler J, Yu H, et al. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 2006; 20: 557-70.
75. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 2001; 15: 2675-86.
76. Jiang BH, Semenza GL, Bauer C, Marti HH. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 1996; 271: C1172-80.
77. Wiesener MS, Jurgensen JS, Rosenberger C, et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003; 17: 271-73.
78. Stroka DM, Burkhardt T, Desbaillets I, et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001; 15: 2445-53.
79. Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2 plays an important role in vascular remodeling. Proc Natl Acad Sci USA 2000; 97: 8386-91.
80. Bae S, Xiao Y, Li G, Casiano CA, Zhang L. Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart. Am J Physiol Heart Circ Physiol 2003; 285: H983-90.
81. Ladoux A, Frelin C. Cardiac expressions of HIF-1 alpha and HLF/EPAS, two basic loop helix/PAS domain transcription factors involved in adaptative responses to hypoxic stresses. Biochem Biophys Res Commun 1997; 240: 552-56.
82. Tillmanns J, Rota M, Hosoda T, et al. Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci USA 2008; 105: 1668-73.
83. Maloyan A, Eli-Berchoer L, Semenza GL, Gerstenblith G, Stern MD, Horowitz M. HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart. Physiol Genomics 2005; 23: 79-88.
84. Wenger RH, Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997; 378: 609-16.
85. Gordan JD, Simon MC. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev 2007; 17: 71-7.
86. Graham RM, Frazier DP, Thompson JW, et al. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 2004; 207: 3189-200.
87. Chen W, Ostrowski RP, Obenaus A, Zhang JH. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol 2009; 216: 7-15.
88. Moore LG, Niermeyer S, Zamudio S: Human adaptation to high altitude: regional and life-cycle perspectives. Am J Phys Anthropol 1998; Suppl 27: 25-64.
89. Zamudio S. The placenta at high altitude. High Alt Med Biol 2003; 4: 171-91.
90. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public health 1997; 87: 1003-7.
91. Moore LG, Zamudio S, Zhuang J, Sun S, Droma T. Oxygen transport in tibetan women during pregnancy at 3,658 m. Am J Phys Anthropol 2001; 114: 42-53.
92. Moore LG. Fetal growth restriction and maternal oxygen transport during high altitude pregnancy. High Alt Med Biol 2003; 4: 141-56.
93. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298: 564-67.
94. Barker DJ. Outcome of low birthweight. Horm Res 1994; 42: 223-30.
95. Barker DJ. Fetal nutrition and cardiovascular disease in later life. Br Med Bull 1997; 53: 96-108.
96. Zhang L. Prenatal hypoxia and cardiac programming. J Soc Gynecol Investig 2005; 12: 2-13.
97. rd ed. Maryland Heights, MO: Elsevier Science. 2007
98. Lueder FL, Kim SB, Buroker CA, Bangalore SA, Ogata ES. Chronic maternal hypoxia retards fetal growth and increases glucose utilization of select fetal tissues in the rat. Metabolism 1995; 44: 532-7.
99. Ream M, Ray AM, Chandra R, Chikaraishi DM. Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol 2008; 292: 583-95.
100. Sharma SK, Lucitti JL, Nordman C, Tinney JP, Tobita K, Keller BB. Impact of hypoxia on early chick embryo growth and cardiovascular function. Pediatr Res 2006; 59: 116-20.
101. Martin C, Yu AY, Jiang BH, et al. Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am J Obstet Gynecol 1998; 178: 527-34.
102. Val'kovich EI, Molchanova VV, Davydova MK, Davydova OK. [Changes in the myocardium of fetuses and newborn infants as a result of hypoxia]. Arkh Anat Gistol Embriol 1986; 90: 35-9.
103. Xiao D, Ducsay CA, Zhang L. Chronic hypoxia and developmental regulation of cytochrome c expression in rats. J Soc Gynecol Investig 2000; 7: 279-83.
104. Thornburg KL. Fetal response to intrauterine stress. Ciba Found Symp 1991; 156: 17-29; discussion 29-37.
105. Sedmera D, Kucera P, Raddatz E. Developmental changes in cardiac recovery from anoxia-reoxygenation. Am J Physiol Regul Integr Comp Physiol 2002; 283: R379-88.
106. Portbury AL, Chandra R, Groelle M, et al. Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 2003; 284: 2069-77.
107. Kamitomo M, Longo LD, Gilbert RD. Cardiac function in fetal sheep during two weeks of hypoxemia. Am J Physiol 1994; 266: R1778-85.
108. Kamitomo M, Onishi J, Gutierrez I, Stiffel VM, Gilbert RD. Effects of long-term hypoxia and development on cardiac contractile proteins in fetal and adult sheep. J Soc Gynecol Investig 2002; 9: 335-41.
109. Gilbert RD. Fetal myocardial responses to long-term hypoxemia. Comp Biochem Physiol A Mol Integr Physiol 1998; 119: 669-74.
110. Browne VA, Stiffel VM, Pearce WJ, Longo LD, Gilbert RD. Activator calcium and myocardial contractility in fetal sheep exposed to long-term high-altitude hypoxia. Am J Physiol 1997; 272: H1196-1204.
111. Onishi J, Browne VA, Kono S, Stiffel VM, Gilbert RD. Effects of long-term high-altitude hypoxia and troponin I phosphorylation on cardiac myofilament calcium responses in fetal and nonpregnant sheep. J Soc Gynecol Investig 2004; 11: 1-8.
112. Tintu A, Rouwet E, Verlohren S, et al. Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences. PLoS One 2009; 4: e5155.
113. Ghatpande SK, Billington CJ Jr, Rivkees SA, Wendler CC. Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryos. Birth Defects Res A Clin Mol Teratol 2008; 82: 121-30.
114. Sarre A, Maury P, Kucera P, Kappenberger L, Raddatz E. Arrhythmogenesis in the developing heart during anoxia-reoxygenation and hypothermia-rewarming: an in vitro model. J Cardiovasc Electrophysiol 2006; 17: 1350-9.
115. Graf AV, Maslova MV, Maklakova AS, et al. Effect of hypoxia during early organogenesis on cardiac activity and noradrenergic regulation in the postnatal period. Bull Exp Biol Med 2006; 142: 543-5.
116. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986; 1: 1077-81.
117. Barker DJ. The fetal and infant origins of adult disease. BMJ 1990; 301: 1111.
118. Lucas A. Programming by early nutrition in man. Ciba Found Symp 1991; 156: 38-50; discussion 50-35.
119. Li G, Xiao Y, Estrella JL, Ducsay CA, Gilbert RD, Zhang L. Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat. J Soc Gynecol Investig 2003; 10: 265-74.
120. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 2001; 81: 1461-97.
121. Sharp BR, Jones SP, Rimmer DM, Lefer DJ. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am J Physiol Heart Circ Physiol 2002; 282: H2422-26.
122. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
123. Okamura T, Miura T, Takemura G, et al. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 2000; 45: 642-50.
124. Xu Y, Williams SJ, O'Brien D, Davidge ST. Hypoxia or nutrient restriction during pregnancy in rats leads to progressive cardiac remodeling and impairs postischemic recovery in adult male offspring. FASEB J 2006; 20: 1251-3.
125. Li G, Bae S, Zhang L. Effect of prenatal hypoxia on heat stress-mediated cardioprotection in adult rat heart. Am J Physiol Heart Circ Physiol 2004; 286: 1717-19.
126. Xue Q, Zhang L. Prenatal hypoxia causes a sex-dependent increase in heart susceptibility to ischemia and reperfusion injury in adult male offspring: Role of PKC{epsilon}. J Pharmacol Exp Ther 2009; 330: 624-32.
127. Saurin AT, Pennington DJ, Raat NJ, Latchman DS, Owen MJ, Marber MS. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res 2002; 55: 672-80.
128. Ping P, Song C, Zhang J, et al. Formation of protein kinase C(epsilon)-Lck signaling modules confers cardioprotection. J Clin Invest 2002; 109: 499-507.
129. Inagaki K, Begley R, Ikeno F, Mochly-Rosen D. Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation 2005; 111: 44-50.
130. Inagaki K, Churchill E, Mochly-Rosen D. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res 2006; 70: 222-30.
131. Netuka I, Szarszoi O, Maly J, et al. Effect of perinatal hypoxia on cardiac tolerance to acute ischaemia in adult male and female rats. Clin Exp Pharmacol Physiol 2006; 33: 714-9.
132. Mao C, Hou J, Ge J, et al. Changes of renal AT(1)/AT(2) receptors and structures in ovine fetuses following exposure to long-term hypoxia. Am J Nephrol 2009; 31: 141-50.
133. Myers DA, Hyatt K, Mlynarczyk M, Bird IM, Ducsay CA. Long-term hypoxia represses the expression of key genes regulating cortisol biosynthesis in the near-term ovine fetus. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1707-14.
134. Levitt NS, Lindsay RS, Holmes MC, Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996; 64: 412-8.
135. McKenna ES, Roberts CW. Epigenetics and cancer without genomic instability. Cell Cycle 2009; 8: 23-6.
136. Hirst M, Marra MA. Epigenetics and human disease. Int J Biochem Cell Biol 2009; 41: 136-46.
137. Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J Cell Physiol 2009; 219: 243-250.
138. Zhang H, Meyer KD, Zhang L. Fetal exposure to cocaine causes programming of Prkce gene repression in the left ventricle of adult rat offspring. Biol Reprod 2009; 80: 440-8.
139. Meyer K, Zhang H, Zhang L: Direct effect of cocaine on epigenetic regulation of PKCvarepsilon gene repression in the fetal rat heart. J Mol Cell Cardiol 2009; 47: 352-8
140. Bae S, Gilbert RD, Ducsay CA, Zhang L. Prenatal cocaine exposure increases heart susceptibility to ischaemia-reperfusion injury in adult male but not female rats. J Physiol 2005; 565: 149-58.
141. Meyer KD Zhang H, Zhang L. Prenatal cocaine exposure abolished ischemic preconditioning-induced protection in adult male rat hearts: role of PKC{varepsilon}. Am J Physiol Heart Circ Physiol 2009; 296: H1566-76.
142. Wu H, Sun YE. Epigenetic regulation of stem cell differentiation. Pediatr Res 2006; 59: 21R-5R.
143. Maltepe E, Krampitz GW, Okazaki KM, et al. Hypoxia-inducible factor-dependent histone deacetylase activity determines stem cell fate in the placenta. Development 2005; 132: 3393-403.
144. Scholer HR, Ruppert S, Suzuki N, Chowdhury K, Gruss P. New type of POU domain in germ line-specific protein Oct-4. Nature 1990; 344: 435-39.
145. Suzuki N, Rohdewohld H, Neuman T, Gruss P, Scholer HR. Oct-6: a POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J 1990, 9: 3723-32.
146. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95: 379-91.
147. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002; 1: 237-46.
148. Gordan JD, Lal P, Dondeti VR, et al. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell 2008; 14: 435-46.
149. Beyer S, Kristensen MM, Jensen KS, Johansen JV, Staller P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J Biol Chem 2008; 283: 36542-52.
150. Wellmann S, Bettkober M, Zelmer A, et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem Biophys Res Commun 2008; 372: 892-7.
151. Chen H, Yan Y, Davidson TL, Shinkai Y, Costa M. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res 2006; 66: 9009-16.
152. Krieg M, Haas R, Brauch H, Acker T, Flamme I, Plate KH. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 2000; 19: 5435-43.
153. Granger A, Abdullah I, Huebner F, et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J 2008; 22: 3549-60.
154. He M, Vanaja DK, Karnes RJ, Young CY. Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells. Prostate 2009; 69: 1643-50.
155. Brenner C, Deplus R, Didelot C, et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J 2005; 24: 336-46.
156. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004; 23: 1949-56.
157. Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing. J Biol Chem 2000; 275: 25130-8.
158. Poyton RO, Ball KA, Castello PR. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab 2009; 20: 332-40.
159. Liu L, Wise DR, Diehl JA, Simon MC. Hypoxic reactive oxygen species regulate the integrated stress response and cell survival. J Biol Chem 2008; 283: 31153-62.
160. Sauer H, Wartenberg M. Reactive oxygen species as signaling molecules in cardiovascular differentiation of embryonic stem cells and tumor-induced angiogenesis. Antioxid Redox Signal 2005; 7: 1423-34.
161. Lim SO, Gu JM, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008; 135: 2128-40, 2140.e1-8.
162. Mansfield KD, Simon MC, Keith B. Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J Appl Physiol 2004; 97: 1358-66.
163. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G: Morphological, biochemical, and electrophy-siological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991; 69: 1476-86.
164. Coles JG, Boscarino C, Takahashi M, et al. Cardioprotective stress response in the human fetal heart. J Thorac Cardiovasc Surg 2005; 129: 1128-36.
165. Hwang JM, Weng YJ, Lin JA, et al. Hypoxia-induced compensatory effect as related to Shh and HIF-1alpha in ischemia embryo rat heart. Mol Cell Biochem 2008; 311: 179-87.
166. Chong KY, Lai CC, Lille S, Chang C, Su CY. Stable overexpression of the constitutive form of heat shock protein 70 confers oxidative protection. J Mol Cell Cardiol 1998; 30: 599-608.